Renedo Daniela, Acosta Julian N, Leasure Audrey C, Sharma Richa, Krumholz Harlan M, de Havenon Adam, Alahdab Fares, Aravkin Aleksandr Y, Aryan Zahra, Bärnighausen Till Winfried, Basu Sanjay, Burkart Katrin, Coberly Kaleb, Criqui Michael H, Dai Xiaochen, Desai Rupak, Dharmaratne Samath Dhamminda, Doshi Rajkumar, Elgendy Islam Y, Feigin Valery L, Filip Irina, Gad Mohamed M, Ghozy Sherief, Hafezi-Nejad Nima, Kalani Rizwan, Karaye Ibraheem M, Kisa Adnan, Krishnamoorthy Vijay, Lo Warren, Mestrovic Tomislav, Miller Ted R, Misganaw Awoke, Mokdad Ali H, Murray Christopher J L, Natto Zuhair S, Radfar Amir, Ram Pradhum, Roth Gregory A, Seylani Allen, Shah Nilay S, Sharma Purva, Sheikh Aziz, Singh Jasvinder A, Song Suhang, Sotoudeh Houman, Vervoort Dominique, Wang Cong, Xiao Hong, Xu Suowen, Zand Ramin, Falcone Guido J, Sheth Kevin N
Department of Neurology, Yale School of Medicine, New Haven, Connecticut.
Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut.
JAMA Neurol. 2024 Mar 4;81(4):394-404. doi: 10.1001/jamaneurol.2024.0190.
Stroke is a leading cause of death and disability in the US. Accurate and updated measures of stroke burden are needed to guide public health policies.
To present burden estimates of ischemic and hemorrhagic stroke in the US in 2019 and describe trends from 1990 to 2019 by age, sex, and geographic location.
DESIGN, SETTING, AND PARTICIPANTS: An in-depth cross-sectional analysis of the 2019 Global Burden of Disease study was conducted. The setting included the time period of 1990 to 2019 in the US. The study encompassed estimates for various types of strokes, including all strokes, ischemic strokes, intracerebral hemorrhages (ICHs), and subarachnoid hemorrhages (SAHs). The 2019 Global Burden of Disease results were released on October 20, 2020.
In this study, no particular exposure was specifically targeted.
The primary focus of this analysis centered on both overall and age-standardized estimates, stroke incidence, prevalence, mortality, and DALYs per 100 000 individuals.
In 2019, the US recorded 7.09 million prevalent strokes (4.07 million women [57.4%]; 3.02 million men [42.6%]), with 5.87 million being ischemic strokes (82.7%). Prevalence also included 0.66 million ICHs and 0.85 million SAHs. Although the absolute numbers of stroke cases, mortality, and DALYs surged from 1990 to 2019, the age-standardized rates either declined or remained steady. Notably, hemorrhagic strokes manifested a substantial increase, especially in mortality, compared with ischemic strokes (incidence of ischemic stroke increased by 13% [95% uncertainty interval (UI), 14.2%-11.9%]; incidence of ICH increased by 39.8% [95% UI, 38.9%-39.7%]; incidence of SAH increased by 50.9% [95% UI, 49.2%-52.6%]). The downturn in stroke mortality plateaued in the recent decade. There was a discernible heterogeneity in stroke burden trends, with older adults (50-74 years) experiencing a decrease in incidence in coastal areas (decreases up to 3.9% in Vermont), in contrast to an uptick observed in younger demographics (15-49 years) in the South and Midwest US (with increases up to 8.4% in Minnesota).
In this cross-sectional study, the declining age-standardized stroke rates over the past 3 decades suggest progress in managing stroke-related outcomes. However, the increasing absolute burden of stroke, coupled with a notable rise in hemorrhagic stroke, suggests an evolving and substantial public health challenge in the US. Moreover, the significant disparities in stroke burden trends across different age groups and geographic locations underscore the necessity for region- and demography-specific interventions and policies to effectively mitigate the multifaceted and escalating burden of stroke in the country.
在美国,中风是导致死亡和残疾的主要原因。需要准确且最新的中风负担衡量指标来指导公共卫生政策。
呈现2019年美国缺血性和出血性中风的负担估计,并描述1990年至2019年按年龄、性别和地理位置划分的趋势。
设计、背景和参与者:对2019年全球疾病负担研究进行了深入的横断面分析。背景涵盖1990年至2019年的美国时间段。该研究包括对各类中风的估计,包括所有中风、缺血性中风、脑出血(ICH)和蛛网膜下腔出血(SAH)。2020年10月20日公布了2019年全球疾病负担结果。
在本研究中,未特别针对特定暴露因素。
本分析的主要重点集中在总体和年龄标准化估计、中风发病率、患病率、死亡率以及每10万人的伤残调整生命年(DALY)。
2019年,美国记录了709万例中风患者(407万女性[57.4%];302万男性[42.6%]),其中587万例为缺血性中风(82.7%)。患病率还包括66万例脑出血和85万例蛛网膜下腔出血。尽管从1990年到2019年中风病例、死亡率和伤残调整生命年的绝对数量激增,但年龄标准化率要么下降要么保持稳定。值得注意的是,与缺血性中风相比,出血性中风尤其是死亡率大幅上升(缺血性中风发病率增加了13%[95%不确定区间(UI),14.2%-11.9%];脑出血发病率增加了39.8%[95%UI,38.9%-39.7%];蛛网膜下腔出血发病率增加了50.9%[95%UI,49.2%-52.6%])。中风死亡率在最近十年趋于平稳。中风负担趋势存在明显的异质性,沿海地区的老年人(50 - 74岁)发病率下降(佛蒙特州下降高达3.9%),而美国南部和中西部的年轻人群(15 - 49岁)发病率上升(明尼苏达州上升高达8.4%)。
在这项横断面研究中,过去三十年年龄标准化中风率下降表明在管理中风相关结局方面取得了进展。然而,中风绝对负担的增加,再加上出血性中风的显著上升,表明美国面临着不断演变且重大的公共卫生挑战。此外,不同年龄组和地理位置之间中风负担趋势的显著差异凸显了针对特定地区和人群制定干预措施和政策的必要性,以有效减轻该国中风多方面且不断升级的负担。